Biomerica (BMRA) Operating Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -7,184.00 |
| Nov 30, 2025 | 1,131.00 |
| Aug 31, 2025 | 6,377.00 |
| May 31, 2025 | -29,966.00 |
| Feb 28, 2025 | -3,039.00 |
| Nov 30, 2024 | -3,002.00 |
| Aug 31, 2024 | -3,304.00 |
| May 31, 2024 | 36,132.00 |
| Feb 29, 2024 | -14,058.00 |
| Nov 30, 2023 | -7,024.00 |
| Aug 31, 2023 | -3,619.00 |
| May 31, 2023 | -10,872.00 |
| Feb 28, 2023 | -12,514.00 |
| Nov 30, 2022 | -9,452.00 |
| Aug 31, 2022 | -11,080.00 |
| May 31, 2022 | -888.00 |
| Feb 28, 2022 | 1,978.00 |
| Nov 30, 2021 | -898.00 |
| Aug 31, 2021 | -11,740.00 |
| May 31, 2021 | -14,291.00 |
| Feb 28, 2021 | -3,990.00 |
| Nov 30, 2020 | -10,678.00 |
| Aug 31, 2020 | -13,887.00 |
| May 31, 2020 | 3,496.00 |
| Feb 29, 2020 | -6,731.00 |
| Nov 30, 2019 | -864.00 |
| Aug 31, 2019 | -2,100.00 |
| May 31, 2019 | 18,747.00 |
| Feb 28, 2019 | -5,826.00 |
| Nov 30, 2018 | -590.00 |
| Aug 31, 2018 | -1,859.00 |
| May 31, 2018 | -3,575.00 |
| Feb 28, 2018 | -1,900.00 |
| Nov 30, 2017 | -3,103.00 |
| Aug 31, 2017 | -3,399.00 |
| May 31, 2017 | -2,811.00 |
| Feb 28, 2017 | -3,006.00 |
| Nov 30, 2016 | -2,733.00 |
| Aug 31, 2016 | -1,296.00 |
| May 31, 2016 | -1,923.00 |
| Feb 29, 2016 | -2,519.00 |
| Nov 30, 2015 | -270.00 |